Health and Life Sciences


The pharmaceutical sector is one of the Romania’s largest suppliers of goods and services, one of the biggest taxpayers contributing to the state budget revenue, as well as the state’s largest creditor. Until 2007, inclusively, the development of the pharmaceutical sector was spectacular. Following that year, a relative stagnation was registered.

There are three great segments in the Romanian pharmaceutical market: producer segment, distributor segment and retailer segment. According to the study entitled "Pharmaceutical industry in Romania: main tendencies and impact on society and economy", carried out by the Institute for Economic Forecasting (IEF), in Romania, in 2010 there were over 180 pharmaceutical producers (domestic and foreign), out of which 10 controlled over 60% of the market.

The top private healthcare operators in Romania will continue to expand despite ongoing political instability leading to constant government reshuffles, industry insiders told Healthcare Europa at HBI 2018.

  • Terapia Ranbaxy Cluj -
  • Antibiotice SA Iasi -
  • Zentiva SA Bucuresti -
  • Sandoz SRL Mures -
  • Alvogen Romania -
  • Biofarm -
  • Infomed Fluids -